Tandem Diabetes Care | TNDM - Sales Revenues



Tandem Diabetes Care reported $240.68M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Abbott USD 11.42B 1.06B Jun/2025
Align Technology USD 1.01B 30.7M Jun/2025
AtriCure USD 136.1M 12.5M Jun/2025
Baxter International USD 2.81B 180M Jun/2025
Becton, Dickinson and Co. USD 5.5B 230M Jun/2025
Boston Scientific USD 5.06B 400M Jun/2025
Cooper Companies USD 1.06B 60.3M Jul/2025
Dexcom USD 1.16B 120M Jun/2025
Edwards Lifesciences USD 1.53B 120M Jun/2025
Eli Lilly USD 15.56B 2.83B Jun/2025
Globus Medical USD 745.3M 147.2M Jun/2025
ICU Medical USD 548.9M 50.59M Jun/2025
Insulet USD 649.1M 80.1M Jun/2025
Integra LifeSciences USD 415.6M 32.9M Jun/2025
Intuitive Surgical USD 2.44B 190M Jun/2025
J&J USD 23.74B 1.85B Jun/2025
Masimo USD 371M 1000K Jun/2025
Medtronic USD 8.6B 330M Jun/2025
Merit Medical Systems USD 382.5M 27.1M Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024
Stryker USD 6.02B 120M Jun/2025
Tandem Diabetes Care USD 240.68M 6.28M Jun/2025
Teleflex USD 780.88M 80.21M Jun/2025
Zimmer Biomet Holdings USD 2.08B 170M Jun/2025